Terlipressin Squeaks by FDA Review for Hepatorenal Syndrome 1

The FDA advisory committee’s 8-7 vote favoring approval of terlipressin for hepatorenal syndrome type 1 reflected concerns and misgivings. Medscape Medical News
Read More

Leave a Reply

%d bloggers like this: